{
  "url": "https://openlegislation.uk/public-health-etc-scotland-act-2008/schedule-1/part-2",
  "json_url": "https://openlegislation.uk/public-health-etc-scotland-act-2008/schedule-1/part-2.json",
  "legislation": "asp/2008/5",
  "legislation_title": "Public Health etc. (Scotland) Act 2008",
  "legislation_url": "https://openlegislation.uk/public-health-etc-scotland-act-2008",
  "path": "schedule/1/part/2",
  "kind": "part",
  "number": "2",
  "heading": "Notifiable organisms",
  "text": "Bacillus anthracis\nBacillus cereus\nBordetella pertussis\nBorrelia burgdorferi\nBrucella genus\nCampylobacter genus\nCarbapenemase-producing Gram-negative organisms (excluding those with intrinsic carbapenem resistance from any human specimen)\nChlamydia psittaci\nClostridium botulinum\nClostridium difficile\nClostridium perfringens\nClostridium tetani\nCorynebacterium diphtheriae (toxigenic strains)\nCorynebacterium ulcerans\nCoxiella burnetii\nCrimean-Congo haemorrhagic fever virus\nCryptosporidium\nDengue virus\nEbola virus\nEchinococcus genus\nVerocytotoxin-producing E.coli (VTEC)\nFrancisella tularensis\nGiardia lamblia\nGuanarito virus\nHaemophilus influenzae type b (from blood, cerebrospinal fluid or other normally sterile site)\nHantavirus\nHepatitis A virus\nHepatitis B virus\nHepatitis C virus\nHepatitis E virus\nInfluenza virus (all types, including those caused by a new sub-type)\nJunín virus\nKyasanur Forest disease virus\nLassa virus\nLegionella genus\nLeptospira genus\nListeria monocytogenes\nMachupo virus\nMarburg virus\nMeasles virus\nMonkeypox virus\nMumps virus\nMycobacterium bovis\nMycobacterium tuberculosis complex\nNeisseria meningitidis\nNorovirus\nOmsk haemorrhagic fever virus\nPlasmodium falciparum, vivax, ovale and malariae\nPolio virus\nRabies virus\nRickettsia prowazekii\nRift Valley fever virus\nRubella virus\nSabia virus\nSalmonella (all human types)\nSARS-associated coronavirus\nSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)\nShigella genus\nEnterotoxigenic Staphylococcus aureus\nStaphylococcus aureus (all blood isolates)\nMethicillin-resistant Staphylococcus aureus (MRSA)\nStreptococcus pyogenes (from blood, cerebrospinal fluid or other normally sterile site)\nStreptococcus pneumoniae (from blood, cerebrospinal fluid or other normally sterile site)\nToxoplasma gondii\nTrichinella genus\nVaricella-zoster virus\nVariola virus\nVibrio cholerae\nWest Nile fever virus\nYellow Fever virus\nYersinia enterocolitica\nYersinia pestis\nYersinia pseudotuberculosis",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "F",
      "label": "F1",
      "text": "Words in sch. 1 Pt. 2 inserted (28.1.2021) by The Public Health etc. (Scotland) Act 2008 (Notifiable Organisms) Amendment Regulations 2020 (S.S.I. 2020/408), regs. 1(2), 2(2)"
    },
    {
      "type": "F",
      "label": "F2",
      "text": "Words in sch. 1 Pt. 2 inserted (16.6.2022 at 5.00 p.m.) by The Public Health etc. (Scotland) Act 2008 (Notifiable Diseases and Notifiable Organisms) Amendment Regulations 2022 (S.S.I. 2022/212), regs. 1(2), 2(b)"
    },
    {
      "type": "F",
      "label": "F3",
      "text": "Words in sch. 1 Pt. 2 inserted (22.2.2020) by The Public Health etc. (Scotland) Act 2008 (Notifiable Diseases and Notifiable Organisms) Amendment Regulations 2020 (S.S.I. 2020/51), regs. 1(2), 2(2)(b)"
    },
    {
      "type": "I",
      "label": "I1",
      "text": "Sch. 1 Pt. 2 in force at 1.1.2010 by S.S.I. 2009/404, art. 2(3), sch. 3"
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/asp/2008/5/schedule/1/part/2",
    "retrieved_at": "2026-10-29T20:15:45.653037+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}